春雨医生的"买方"国锐生活是一家主营物业开发与投资、物业管理服务的香港上市公司，正在寻求业务多元化发展。其2024年物业管理服务收入同比减少 17%，投资物业公允价值净亏损高达9.348亿港元。 中国商报（记者 马嘉）2015年，互联网医疗行业融资总额曾一度超过200亿元。而到2025年岁末，春雨医生以2.69亿元的价格被一家物业管理公司收购，好 大夫在线被蚂蚁集团收购后声量渐小，多家互联网医疗企业股价缩水……从"颠覆医疗"到陆续"卖身"，才不过十年光景。互联网医疗企业是走到了阶段性发 展的终点，还是成熟的开始？ 图为在首都医科大学附属北京朝阳医院本部，医生正在通过互联网医院为患者进行在线诊疗。（图片由CNSPHOTO提供） 春雨医生估值大幅缩水 2025年初冬，春雨医生创始人张锐的遗孀王羽潇在收购协议上签下名字，这意味着曾被誉为"移动医疗第一股"有力竞争者的明星企业，最终被一家物业管理 公司以2.69亿元收购了78.3%的股权。 2016年，春雨医生完成由东证资本投资的12亿元人民币Pre-IPO轮融资，公司估值一度突破10亿美元，成为互联网医疗赛道的耀眼明星。然而，将近10年 后，这家明星企业的整体估值仅 ...

当家庭服务从"基础需求"迈向"品质追求"，山东服务消费市场正迎来深刻变革。在这场升级浪潮中，从莱州走出的山东尚伟家政服务有限公司，凭借"尚 仁、尚智、尚礼"的初心与全方位的服务创新，跻身山东省服务消费新品牌入围阵营。十年深耕，这家从千年古邑起步的家政企业，已成长为辐射全省、 链接国际的行业标杆，用专业与温度为5万多个家庭编织起幸福纽带，更以党建引领的发展模式，为家政服务行业树立了品质典范。 党建为魂，让服务更有底色。2018年，在市委组织部引领下，尚伟家政成立社会组织党支部，创新提出"党建+匠心+挚爱"服务理念，将红色基因融入家 政服务的每一个环节。"擦亮初心底色，锻造业内头雁"的党建口号蔚然成风，工会牵头成立的家政工会委员会，通过"以工助学、以工养学"的订单式培 训，让"成就一个学员，就成就一个家庭"的承诺落地生根。这种"党建引领+工会保障"的模式，不仅让服务人员的道德素养显著提升，更构建起"政府放 心、家庭安心、从业者舒心"的信任体系，就像襄州党建引领家政服务的成功实践那样，将组织优势转化为服务效能。 诚信为尺，让消费更加安心。作为商务部家政信用信息平台入驻企业，尚伟家政将"诚"字贯穿服务全程，定期开展诚 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：000516 证券简称：国际医学 公告编号：2025-054 西安国际医学投资股份有限公司关于2025年度 向特定对象发行股票不存在直接或通过利益 相关方向发行对象提供财务资助或补偿的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 西安国际医学投资股份有限公司（以下简称"公司"）于2025年12月3日召开第十三届董事会第九次会 议，审议通过了关于公司2025年度向特定对象发行股票的相关议案。现就公司本次向特定对象发行股票 中公司不存在直接或通过利益相关方向参与认购的投资者提供财务资助或补偿事宜，公司承诺如下： 西安国际医学投资股份有限公司董事会 二○二五年十二月四日 证券代码：000516 证券简称：国际医学 公告编号：2025-053 西安国际医学投资股份有限公司关于2025年度向特定对象发行股票摊薄即期回报的风险提示及填补回报 措施和相关主体承诺的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 重要内容提示： 本公告中关于西安国际医学投 ...

Core Viewpoint - Eddiecon Holdings (09860) announced the acquisition of 100% of the issued shares of Crown Bioscience International for a total purchase price of $204 million, which aligns with the company's strategy to expand its product portfolio and is expected to bring long-term strategic benefits [1][2]. Group 1: Acquisition Details - The buyer, Miramar Lifesciences Limited, a wholly-owned subsidiary of Eddiecon, entered into a share purchase agreement with the seller, JSR Life Sciences, LLC, regarding the acquisition of the target company [1]. - Upon completion of the transaction, Crown Bioscience International will become a wholly-owned subsidiary of Miramar Lifesciences Limited [1]. - The target company is a global Contract Research Organization (CRO) focused on advancing precision medicine in oncology, immuno-oncology, and other therapeutic areas [1]. Group 2: Company Operations - Eddiecon primarily provides Integrated Clinical Laboratory (ICL) services, along with medical testing, clinical trials, research services, health management, and pathology consultation services [1]. - The company focuses on research and development in core disease areas such as infectious diseases, women's health, solid tumors, perinatal and pediatric care, and hematology, covering multiple disciplines including internal medicine, pediatrics, obstetrics and gynecology, oncology, and neurology [1].

Core Viewpoint - The acquisition of Crown Bioscience International by Miramar Lifesciences Limited for a total purchase price of $204 million is expected to enhance the product portfolio of the company and provide long-term strategic benefits [1][2]. Company Overview - The target company, Crown Bioscience International, is a global Contract Research Organization (CRO) focused on advancing precision medicine in oncology, immuno-oncology, and other therapeutic areas [1]. - The company collaborates with biotechnology and pharmaceutical firms to accelerate drug development through integrated preclinical, translational, and clinical biomarker services [1]. Strategic Rationale - The board believes that the acquisition aligns with the group's development strategy to expand its product offerings [2]. - The acquisition is anticipated to bring long-term and strategic benefits to the company [2].

Core Insights - The company aims to develop a differentiated strategy to build competitive advantages and enhance service value [2] Business Strategy - The company plans to adjust its business structure by actively laying out in various sectors including medical aesthetics, rehabilitation, women's and children's health, health management, traditional Chinese medicine, assisted reproduction, mental health, and special services [2] - The company intends to expand its services by opening elderly care facilities and specialized departments such as proton therapy to meet market demand [2] Operational Efficiency - The company will focus on resource integration and departmental optimization, strengthening cost control and management of pharmaceutical supplies, while optimizing financial costs [2]

Core Viewpoint - The strategic cooperation agreement between Wisdom Eye Technology Co., Ltd. and Hunan Qilin Xinan Technology Co., Ltd. aims to create an innovative and secure "AI + operating system" solution, focusing on key sectors such as healthcare and social security, contributing to the national "Healthy China" strategy and the development of the domestic innovation industry [2][3]. Group 1: Technical Collaboration - The partnership leverages the complementary strengths of both companies, combining Wisdom Eye's AI capabilities with Qilin Xinan's operating system expertise to meet the urgent industry demands for advanced technology, data security, and independent innovation [3][4]. - Wisdom Eye's AI applications, including its "Bianshi" model and intelligent medical insurance supervision, will be optimized for compatibility with Qilin Xinan's operating systems and security products, enhancing performance and compliance in high-security environments [4][5]. Group 2: Industry Solutions - The collaboration will focus on developing integrated hardware and software solutions to address core challenges in the healthcare sector, including smart medical insurance, smart healthcare, and chronic disease prevention [4][5]. - Both companies will work together to provide leading-edge, secure, and compliant services to industry users, supporting the construction of regional health platforms and the high-quality development of the healthcare industry [4][5]. Group 3: Market and Ecosystem Development - The partnership will enhance brand influence through mutual recommendations and joint efforts in sectors such as medical insurance, health, energy, and finance [6]. - Both companies will actively participate in the formulation of technical standards and safety regulations in the field of AI and basic software integration, promoting the large-scale application of domestic technologies in key industries [6].

Group 1 - The core issue involves the internal control management inadequacies in the intermediary business channels of Taiping Pension Insurance Co., Ltd. Jilin Branch, leading to administrative penalties [1][2] - Taiping Pension Insurance Co., Ltd. Jilin Branch was fined 10,000 yuan, while individual Sun Xiaoyu received a fine of 5,000 yuan for their respective roles in the violations [1][2] - The company has previously been listed as operating abnormally due to failure to publicly disclose annual reports as required [3] Group 2 - Taiping Pension Insurance Co., Ltd. was established in 2004 and is a key subsidiary of China Taiping Insurance Group Co., Ltd., specializing in pension and employee welfare insurance services [5] - The company's pension services include enterprise annuities, occupational annuities, and pension security for various enterprises and institutions, while its employee welfare services cover life insurance, accident insurance, supplementary medical insurance, and health management [5]

Core Viewpoint - The conference aimed to explore the current application status and development trends of artificial intelligence in the medical field, providing insights for the compilation of the "2025 AI + Medical Industry Application Map" [2][3] Group 1: AI in Medical Applications - Representatives from AI and medical sectors discussed key topics such as technological innovation, scenario implementation, and ecological collaboration in AI medical applications [2] - AI technologies are being applied in various scenarios including clinical auxiliary diagnosis, health management, medical imaging, and drug development [2] Group 2: Industry Challenges - The conference addressed common challenges faced by the industry, including data compliance, optimization of computing costs, and the cultivation of interdisciplinary talent [2] Group 3: Future Directions - There is a consensus on the need to strengthen collaboration among industry, academia, and research to promote deep integration of AI and the medical industry [2] - Future efforts should focus on accelerating the development of technical standards, clinical value verification, and exploration of business models to help Shanghai become a global hub for AI medical innovation [2]

Core Insights - Health 160 International Limited has successfully passed the listing hearing on the Hong Kong Stock Exchange, marking a significant milestone for the digital health sector in China [1] - The company, established in 2005, is one of the early entrants in the "Internet + Healthcare" space, offering a comprehensive service system that includes appointment booking, online consultations, health management, pharmaceutical e-commerce, and medical information technology [1] - Health 160 has connected with over a thousand large hospitals nationwide, boasting over 100 million registered users and an average daily service volume of one million, showcasing its competitive advantage in digital healthcare services [1] Company Plans - The successful listing hearing is a validation of Health 160's business model and growth prospects, providing strong capital support for future expansion [1] - The company plans to use the raised funds for technology research and development, market expansion, and strategic investments, particularly in AI-assisted diagnosis, chronic disease management, and smart hospital solutions [1] Industry Impact - Analysts suggest that Health 160's listing will accelerate the consolidation of the digital health industry, directing more resources towards leading platforms and enhancing the accessibility and efficiency of public health services [1]